Early salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: Its impact and optimal candidate

Asia-Pacific Journal of Clinical Oncology
Natsuo TomitaYuta Shibamoto

Abstract

We aimed to identify the optimal candidates for early salvage radiotherapy (SRT) among patients with biochemical recurrence (BCR) after radical prostatectomy (RP). This multi-institutional retrospective study included 371 patients treated using SRT after RP. The median (range) PSA level at BCR was 0.36 (0.10-2.00) ng/mL. The association between early SRT (ie, starting PSA level < 0.50) and BCR after SRT was tested in each subgroup according to our own risk stratification. The median follow-up time was 51 months. By multivariate analysis, pT3b, Gleason score ≥ 8, negative surgical margins, PSA doubling time < 6 months, and non-early SRT were associated with BCR after SRT. Patients were stratified by four risk factors other than non-early SRT: (1) low risk (0 risk factor), (2) intermediate risk (1 risk factor), and (3) high risk (≥2 risk factors). The BCR-free survival was higher in the early SRT group than the nonearly SRT group in the high-risk subgroup (P = 0.020), whereas that was similar between two groups in the low-risk and intermediate-risk subgroups (P = .79 and .18, respectively). Multivariate analysis revealed that early SRT was beneficial for the high-risk subgroup (P = .032), whereas early SRT was not associated with...Continue Reading

References

May 11, 1999·JAMA : the Journal of the American Medical Association·C R PoundP C Walsh
Apr 11, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C CattonM Milosevic
May 18, 2006·Journal of the National Cancer Institute·Andrew J StephensonMichael W Kattan
May 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew J StephensonAlan Pollack
May 30, 2009·Journal of Cancer Research and Clinical Oncology·Natsuo TomitaNorio Hayashi
Sep 29, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nitin OhriTimothy N Showalter
Nov 29, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Alessandra SiegmannThomas Wiegel
Dec 29, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Paolo Dell'OglioAlberto Briganti
Jan 7, 2016·Journal of the National Comprehensive Cancer Network : JNCCN·James L MohlerDeborah A Freedman-Cass
Aug 3, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley J StishSteven J Buskirk
Aug 17, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rahul D TendulkarAndrew J Stephenson
Nov 20, 2016·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Christopher R King
Feb 2, 2017·The New England Journal of Medicine·William U ShipleyUNKNOWN NRG Oncology RTOG
Nov 7, 2017·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Pirus GhadjarUNKNOWN Swiss Group for Clinical Cancer Research (SAKK)
Nov 15, 2017·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Keelan ByrneGeorge Hruby
May 19, 2018·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Arunan SujenthiranAjay Aggarwal
Jul 25, 2018·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Hester LiengAndrew Kneebone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved